Glycoprotein CA125A (cancer antigen 125, also known as mucin 16 [MUC16]), which is overexpressed in most serous ovarian cancers and is used as a diagnostic serum biomarker, was also assessed (Felder et al., 2014). This evidence concerns the gene ART4 and ovarian serous adenocarcinoma.